A Double-blind, Placebo-controlled, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Inhaled Doses of AZD8848 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 15 Jun 2016
At a glance
- Drugs DSP 3025 (Primary)
- Indications Allergic asthma; Seasonal allergic rhinitis
- Focus Adverse reactions
- Sponsors AstraZeneca
- 04 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 May 2014 Planned End Date changed from 1 Apr 2015 to 1 Jul 2014 as reported by ClinicalTrials.gov.
- 13 May 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.